Evidence map›Paper›PMID 42305530›Full record

ArticleFrontiers in immunology2026

CD4/CD8 ratio is associated with structural reorganization of vaccine-induced immune responses in people living with HIV.

Faith Jessica Paran, Mizue Saita, Rieko Oyama, Namiko Nomura, Kaori Saito, Abdullah Khasawneh, Pei Gao, Songling Li, Hendra Saputra Ismanto, Noriyo Nagata and 8 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Faith Jessica Paran *Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.
Mizue Saita *Department of General Medicine, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.
Rieko Oyama *Bioresource Research Center, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.
Namiko NomuraBioresource Research Center, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.
Kaori SaitoBioresource Research Center, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.
Abdullah KhasawnehLeading Center for the Development and Research of Cancer Medicine, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.
Pei GaoFaculty of Pharmacy, Juntendo University Graduate School of Medicine, Bunkyō, Japan.
Songling LiDepartment of Genome Informatics, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Hendra Saputra IsmantoDepartment of Genome Informatics, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Noriyo NagataDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Toyama, Japan.
Naoko IwataDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Toyama, Japan.
Yasushi OkazakiDiagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.
Tadaki SuzukiDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Toyama, Japan.
Yuki UeharaBioresource Research Center, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.
Kazuhisa TakahashiBioresource Research Center, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.
Daron M StandleyDepartment of Genome Informatics, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Yoko TabeBioresource Research Center, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.
Toshio NaitoDepartment of General Medicine, Graduate School of Medicine, Juntendo University, Bunkyō, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite effective antiretroviral therapy and sustained viral suppression, people living with HIV (PLWH) continue to exhibit persistent immune activation and low-grade inflammation. Although the CD4/CD8 ratio is routinely monitored as a marker of immune health, the mechanisms underlying residual immune dysregulation remain incompletely understood. Methods: Peripheral blood mononuclear cells from PLWH and HC were collected before and one month after two doses of mRNA vaccination and analyzed by single-cell RNA sequencing with paired TCR profiling. Differential gene expression (DGE) and protein-protein interaction (PPI) network analyses were performed, and node degree distributions were compared among groups. TCR and bulk BCR repertoires were analyzed, and neutralizing antibody responses were assessed. PLWH were stratified by CD4/CD8 ratio. Results: Stratification by CD4/CD8 ratio revealed distinct immune states in PLWH. Differential genes from the normal CD4/CD8 ratios showed focused transcriptional activation with coordinated chemokine-associated communication, whereas those with low CD4/CD8 ratios exhibited broad transcriptional dysregulation and structural reorganization of gene-expression networks. This network signature was characterized by altered PPI topology and significantly increased monocyte-specific node degree, independent of overall transcriptional complexity. Repertoire analyses demonstrated clonal skewing and reduced clonotype diversity in the low CD4/CD8 ratio group, consistent with impaired immune coordination. Conclusion: Vaccine-induced immune responses in PLWH are shaped by network-level organization associated with CD4/CD8 ratio-defined immune states. Low CD4/CD8 ratio group showed increased monocyte-specific PPI connectivity and clonal imbalance, suggesting altered vaccine-induced response dynamics not captured by conventional clinical markers.

Indexed as

AIDS VaccinesCD4-CD8 RatioCD8-Positive T-LymphocytesHIV InfectionsAdultAntibodies, NeutralizingCD4-Positive T-LymphocytesFemaleHumansMaleMiddle AgedProtein Interaction MapsReceptors, Antigen, T-CellAIDS VaccinesAntibodies, NeutralizingReceptors, Antigen, T-CellCOVID-19 mRNA vaccinationHIVimmune dysregulationprotein-protein-interaction networksrepertoire analysisscRNA sequencing analysis

Identifiers

PMID42305530
PMCPMC13265532

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.